We are live on ! Find out more
VIVE

VIVEVE MED INC

Delisted

VIVE was delisted on the 18th of January, 2023.

30 hedge funds and large institutions have $7.82M invested in VIVEVE MED INC in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3030 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

70% less capital invested

Capital invested by funds: $26M → $7.82M (-$18.2M)

Holders
30
Holders Change
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
5
Reduced
7
Closed
6
Calls
Puts
Net Calls
Net Calls Change

VIVE Hedge Fund Activity: Q2 2019 in Review

30 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q2 2019, worth a combined $7.82M — down 70% from $26M a quarter earlier.

Fund positioning in VIVE was balanced in Q2 2019: 6 funds opened new positions, 6 closed out, 5 added to existing stakes and 7 trimmed.

The largest buyer was Stifel Financial, opening a new position worth an estimated $171K. The largest seller was Hood River Capital Management, exiting entirely with an estimated $2.79M sold.

  • 30 institutional investors held VIVEVE MED INC (VIVE) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $7.82M of VIVEVE MED INC stock for Q2 2019, down 70% quarter-over-quarter.
  • 6 funds opened new VIVEVE MED INC positions in Q2 2019 and 6 closed out, a net change of 0 holders.
  • The largest VIVEVE MED INC buyer in Q2 2019 was Stifel Financial, an estimated $171K added.
  • The largest VIVEVE MED INC seller in Q2 2019 was Hood River Capital Management, an estimated $2.79M sold.

Based on aggregated 13F filings for Q2 2019.